 |
San Francisco’s LaunchSquad handles Ellume, which received Food and Drug Administration emergency authorization on Dec. 15 as the first over-the-counter at-home COVID-19 test.
The Ellume COVID-19 Home Test detects active COVID-19 in individuals with or without symptoms in people aged two and up.
The Australian-based company submitted data to the FDA from an independently run clinical study that found the kit demonstrated 96 percent accuracy.
Ellum, which received a $30M grant from the National Institutes of Health, plans to ramp up production to 100K kits per-day in January.
It plans to deliver 20M kits, which will cost less than $30 each, to the US during the first half of 2021.
Sean Parsons, Ellume founder/CEO, called the company’s test kit “an important first line of defense” against the virus.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
